menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Addressing Tuberculosis and Multi-Drug Resistance at a Cellular Level

close
Addressing Tuberculosis and Multi-Drug Resistance at a Cellular Level
Restart
Resume
Read full article
Choose a format
Media formats available:
Details
Presenters
Comments
  • Overview

    Mycobacterium tuberculosis, the bacteria that causes tuberculosis (TB) has been present in the human population since antiquity. Today over 2 billion people have been exposed. What can we learn form this remarkably resilient bacteria, and how do we address the formidable challenge of treating drug resistant strains? Dr. Jeffrey Cirillo, associate professor of microbial and molecular pathogenesis at the Texas A&M Health Science Center College of Medicine, examines tuberculosis from molecular to organ-specific levels and outlines the emergence of multidrug resistance across the world. Hosted by Dr. Mary Leuchars.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Mycobacterium tuberculosis, the bacteria that causes tuberculosis (TB) has been present in the human population since antiquity. Today over 2 billion people have been exposed. What can we learn form this remarkably resilient bacteria, and how do we address the formidable challenge of treating drug resistant strains? Dr. Jeffrey Cirillo, associate professor of microbial and molecular pathogenesis at the Texas A&M Health Science Center College of Medicine, examines tuberculosis from molecular to organ-specific levels and outlines the emergence of multidrug resistance across the world. Hosted by Dr. Mary Leuchars.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 10/25/20